Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report.
Leoni
F
F
Ciolli
S
S
Nozzoli
C
C
Santini
V
V
Fanci
R
R
Rossi Ferrini
P
P
D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000592:standards / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage / Q000592:standards; D018572:Disease-Free Survival; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D019772:Topotecan / Q000008:administration & dosage / Q000592:standards; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000592:standards
D003561:Cytarabine; D019772:Topotecan; D014740:Vidarabine; C024352:fludarabine